Taking Conflicts of Interest Seriously without Overdoing It: Promises and Perils of Academic-Industry Partnerships
- 1 September 2008
- journal article
- Published by Springer Nature in Journal of Academic Ethics
- Vol. 6 (3) , 229-243
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- The impact of greed on academic medicine and patient careNature Biotechnology, 2008
- How pharmaceutical industry funding affects trial outcomes: Causal structures and responsesSocial Science & Medicine, 2008
- Guest Authorship and Ghostwriting in Publications Related to RofecoxibJAMA, 2008
- Special Issue Editors' Statement: Helping Consumers Help ThemselvesJournal of Public Policy & Marketing, 2006
- Finding improved medicines: the role of academic–industrial collaborationNature Reviews Drug Discovery, 2005
- Regulating Academic–Industrial Research Relationships — Solving Problems or Stifling Progress?New England Journal of Medicine, 2005
- Implications of Pharmaceutical Industry Funding on Clinical ResearchAnnals of Pharmacotherapy, 2005
- The Dirt on Coming Clean: Perverse Effects of Disclosing Conflicts of InterestThe Journal of Legal Studies, 2005
- Evidence b(i)ased medicine—selective reporting from studies sponsored by pharmaceutical industry: review of studies in new drug applicationsBMJ, 2003
- Company, academics argue over dataNature Biotechnology, 2000